IRIS
SMIRNE, Carlo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.447
EU - Europa 3.402
AS - Asia 2.356
SA - Sud America 320
Continente sconosciuto - Info sul continente non disponibili 123
AF - Africa 70
OC - Oceania 7
Totale 9.725
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.348
SG - Singapore 938
RU - Federazione Russa 855
IE - Irlanda 604
CN - Cina 486
IT - Italia 463
DE - Germania 378
SE - Svezia 315
VN - Vietnam 307
HK - Hong Kong 267
BR - Brasile 246
FR - Francia 227
UA - Ucraina 199
FI - Finlandia 126
IN - India 103
GB - Regno Unito 86
KR - Corea 56
CA - Canada 51
BD - Bangladesh 42
ID - Indonesia 42
AR - Argentina 33
PL - Polonia 30
BJ - Benin 25
MX - Messico 23
AT - Austria 22
CZ - Repubblica Ceca 22
ZA - Sudafrica 20
NL - Olanda 17
BE - Belgio 16
TR - Turchia 16
JP - Giappone 15
IQ - Iraq 14
EC - Ecuador 12
CL - Cile 11
ES - Italia 10
IR - Iran 9
PH - Filippine 8
AU - Australia 7
CO - Colombia 7
JO - Giordania 6
KE - Kenya 6
PK - Pakistan 6
TH - Thailandia 6
UZ - Uzbekistan 6
AL - Albania 5
CH - Svizzera 5
EG - Egitto 5
VE - Venezuela 5
DZ - Algeria 4
LT - Lituania 4
NP - Nepal 4
PY - Paraguay 4
AE - Emirati Arabi Uniti 3
CR - Costa Rica 3
GT - Guatemala 3
HN - Honduras 3
JM - Giamaica 3
MA - Marocco 3
OM - Oman 3
PR - Porto Rico 3
SA - Arabia Saudita 3
SV - El Salvador 3
TT - Trinidad e Tobago 3
AZ - Azerbaigian 2
DO - Repubblica Dominicana 2
HR - Croazia 2
IL - Israele 2
LV - Lettonia 2
MD - Moldavia 2
MK - Macedonia 2
MY - Malesia 2
PS - Palestinian Territory 2
PT - Portogallo 2
RO - Romania 2
RS - Serbia 2
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BO - Bolivia 1
BS - Bahamas 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CY - Cipro 1
ET - Etiopia 1
GH - Ghana 1
GM - Gambi 1
IM - Isola di Man 1
KW - Kuwait 1
KZ - Kazakistan 1
LB - Libano 1
LY - Libia 1
PA - Panama 1
PE - Perù 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 9.603
Salva come PNG Salva come JPEG
Città #
Dublin 604
San Jose 439
Jacksonville 361
Hong Kong 262
Ashburn 228
Council Bluffs 217
Singapore 197
Dearborn 166
Chandler 152
Beijing 140
Los Angeles 98
Columbus 93
Ho Chi Minh City 92
Wilmington 91
Moscow 87
Ann Arbor 81
Piemonte 76
Lauterbourg 72
Lawrence 71
Princeton 71
Hanoi 70
Milan 64
San Mateo 58
Seoul 53
Buffalo 49
Novara 46
Munich 42
New York 42
Santa Clara 42
Andover 41
Turin 33
São Paulo 31
Jakarta 29
Nuremberg 27
Frankfurt am Main 26
Warsaw 26
Cotonou 25
Houston 25
Brooklyn 22
Atlanta 21
Helsinki 21
Brno 20
Dallas 20
Orem 19
Chicago 18
Denver 18
Guangzhou 18
Nanjing 18
Hillsboro 17
Brussels 16
Dong Ket 16
Rome 16
Boardman 15
Johannesburg 15
Chennai 14
Haiphong 14
Tianjin 14
Toronto 14
Hefei 13
London 13
Woodbridge 13
Poplar 12
Redondo Beach 12
Stockholm 12
Da Nang 11
Falkenstein 11
Mexico City 11
Norwalk 11
Shanghai 11
Tokyo 11
Düsseldorf 10
Montreal 10
Mumbai 10
Boston 9
Manchester 9
Philadelphia 9
Seattle 9
Bremen 8
Phoenix 8
Turku 8
Augusta 7
City of London 7
Grafing 7
Strasbourg 7
Vercelli 7
Alessandria 6
Amman 6
Berlin 6
Fairfield 6
Hangzhou 6
Jinan 6
Kunming 6
Muskogee 6
Nairobi 6
Amsterdam 5
Ankara 5
Baghdad 5
Biên Hòa 5
Bologna 5
Brasília 5
Totale 5.023
Salva come PNG Salva come JPEG
Nome #
Expression of the interferon-inducible proteins MxA and IFI16 in liver allografts 282
Fatality rate and predictors of mortality in an Italian cohort of hospitalized COVID-19 patients 263
Genetic polymorphisms of inflammatory cytokines and liver fibrosis progression due to recurrent hepatitis C 232
Simple Parameters from Complete Blood Count Predict In-Hospital Mortality in COVID-19 204
Contribution of Atrial Fibrillation to In-Hospital Mortality in Patients With COVID-19 193
Response rates to direct antiviral agents among hepatitis C virus infected patients who develop hepatocellular carcinoma following direct antiviral agents treatment 169
Antiviral treatment of hepatitis C improves glucose metabolism along the entire spectrum from normal glucose tolerance to diabetes 152
Validation of the Hepatoma Arterial Embolization Prognostic Score in European and Asian Populations and Proposed Modification. 143
Detrimental Impact of Interferon-Based Regimens for Chronic Hepatitis C on Vitamin D/Parathyroid Hormone Homeostasis 143
Oxidative Stress in Non-Alcoholic Fatty Liver Disease 140
Evaluation of the red cell distribution width as a biomarker of early mortality in hepatocellular carcinoma 137
Red cell distribution width and platelet count as biomarkers of pulmonary arterial hypertension in patients with connective tissue disorders 137
Plasma microvesicles in patients admitted to the emergency department for mild traumatic brain injury: First clues to understand their role 134
Combined sequential use of HAP and ART scores to predict survival outcome and treatment failure following chemoembolization in hepatocellular carcinoma: A multi-center comparative study 132
Improvement of insulin sensitivity in diabetic and non diabetic patients with chronic hepatitis C treated with direct antiviral agents 132
Gas6/TAM Signaling Components as Novel Biomarkers of Liver Fibrosis 131
Aberrant activation of c-kit protects colon carcinoma cells against apoptosis and enhances their invasive potential 130
Asymptomatic HBV and HCV carriers, bad breath and gengivitis 128
Diagnostic value of FibroTest with normal serum aminotransferases 127
Unusual presentation of fatal disseminated varicella zoster virus infection in a patient with lupus nephritis: A case report 127
Extracellular Vesicles as a Potential Biomarker of Pulmonary Arterial Hypertension in Systemic Sclerosis 121
Differential expression of transforming growth factors-beta1, -beta2 and -beta3 in human colon carcinoma 121
Cooperative induction of a tolerogenic dendritic cell phenotype by cytokines secreted by pancreatic carcinoma cells 119
The ALBI grade provides objective hepatic reserve estimation across each BCLC stage of hepatocellular carcinoma 119
APOLIPOPROTEIN E GENOTYPES MODULATE FIBROSIS PROGRESSION IN PATIENTS WITH CHRONIC HEPATITIS C AND PERSISTENTLY NORMAL TRANSAMINASES 118
The surgical treatment of lung metastases. The prognostic factors and the indications for the surgical approach 117
Antagonistic interactions between gemcitabine and 5-fluorouracil in the human pancreatic carcinoma cell line Capan-2 117
Assessment of liver fibrosis progression in patients with chronic hepatitis C and normal alanine aminotransferase values: the role of the AST to platelet ratio index 117
Periostin Circulating Levels and Genetic Variants in Patients with Non-Alcoholic Fatty Liver Disease 117
ACE genotype, body weight changes and target organ damage in renal transplant recipients 116
Role of Gas6 and TAM Receptors in the Identification of Cardiopulmonary Involvement in Systemic Sclerosis and Scleroderma Spectrum Disorders 113
Risk of hepatocellular carcinoma and death among cirrhotics who carry genetic variants of epidermal growth factor, Adiponutrin and 17β-Hydroxysteroid Dehydrogenase-13: a long-term cohort study 112
IL28B Polymorphism, Blood Interferon-alpha Concentration, and Disease Stage of HCV Mono-infected and HCV-HIV Co-infected Patients. 112
Role of the co-stimulatory molecule inducible T-cell co-stimulator ligand (ICOSL) in the progression of experimental metabolic dysfunction-associated steatohepatitis 111
Cytokine expression profile in human pancreatic carcinoma cells and in surgical specimens: implications for survival 110
Interferon alpha concentrations in blood and peritoneal fluid during treatment for hepatitis C 109
Fibrosis Progression in HCV Carriers with Mild Hepatitis Who Possess the High-Repetition Variant of the DRD4 Gene, a Genetic Marker for Binge-Drinking and Risk-Seeking Behavior: A Longitudinal Study. 108
Chlamydia trachomatis prevalence in North-West Italy 107
Sofosbuvir-based therapies in genotype 2 hepatitis C virus cirrhosis: A real-life experience with focus on ribavirin dose 107
Plasma Pattern of Extracellular Vesicles Isolated from Hepatitis C Virus Patients and Their Effects on Human Vascular Endothelial Cells 106
Low fibrosis progression of recurrent hepatitis C in apolipoprotein E epsilon4 carriers: relationship with the blood lipid profile 106
Chronic Hepatitis C Infection Treated with Direct-Acting Antiviral Agents and Occurrence/Recurrence of Hepatocellular Carcinoma: Does It Still Matter? 104
The spectrum of movement disorders in chronic liver disease: A cross-sectional study 104
Acquired post partum hemophilia 103
Durability of the response to peginterferon-α2b and ribavirin in patients with chronic hepatitis C 101
The spectrum of movement disorders in chronic liver disease: a cross-sectional study 101
Genetic polymorphisms of interleukin-6 modulate fibrosis progression in mild chronic hepatitis C. 99
Influence of angiotensin-converting enzyme I/D gene polymorphism on clinical and histological correlates of chronic hepatitis C 98
Plasma Extracellular Vesicles from Preeclamptic Patients Trigger a Detrimental Crosstalk Between Glomerular Endothelial Cells and Podocytes Involving Endothelin-1 96
Clinical Characteristics and Outcomes in Patients with Chronic HBV Infection and Hospitalized for COVID-19 Pneumonia: A Retrospective Cohort Study 96
T-cell mediated responses against alpha-foetoprotein in hepatocellular carcinoma: Relationship with hepatitis C virus infection, tumour phenotype and patients’ survival 96
Human pancreatic carcinoma cells secrete bioactive interleukin-18 after treatment with 5-fluorouracil: implications for anti-tumor immune response 95
Use, misuse and abuse of diuretics 92
Hepatitis C in the elderly: a multicentre cross-sectional study by the Italian Association for the Study of the Liver. 91
Vascular endothelial growth factor. From basic research to clinical application 91
Excess body weight, liver steatosis, and early fibrosis progression due to hepatitis C recurrence after liver transplantation 90
Efficacy and Safety of Sofosbuvir and Ribavirin in an Italian Cohort of HCV Genotype 2 Elderly Cirrhotic Patients 88
High serum levels of Transforming Growth Factor-beta1, Interleukin-10 and Vascular Endothelial Growth Factor in pancreatic adenocarcinoma patients 88
Imatinib mesylate for the treatment of solid tumours: Recent trials and future directions 88
Hepatic arterial infusion chemotherapy for Production and pro-apoptotic activity of soluble CD95 ligand in pancreatic carcinoma 88
Clinical Features and Outcomes of Patients with Full Spectrum of COVID-19 Severity and Concomitant Herpesvirus Reactivation 87
Exposure to Plasma From Non-alcoholic Fatty Liver Disease Patients Affects Hepatocyte Viability, Generates Mitochondrial Dysfunction, and Modulates Pathways Involved in Fat Accumulation and Inflammation 87
Unsuspected strongyloidiasis in hospitalized elderly patients with and without eosinophilia 87
Liver biopsy and noninvasive alternatives in relationship to the duration of antiviral treatment for hepatitis C 86
Production and pro-apoptotic activity of soluble CD95 ligand in pancreatic carcinoma 86
Sex-related influence of angiotensin-converting enzyme polymorphisms on fibrosis progression due to recurrent hepatitis C after liver transplantation 85
Impact of Age and Sex on Viral Load in Hepatitis C Virus Infection 84
The spectrum of movement disorders in chronic liver disease: a cross-sectional study 83
A novel likely pathogenetic variant p.(Cys235Arg) of the MEN1 gene in multiple endocrine neoplasia type 1 with multifocal glucagonomas. 82
Sexually transmitted diseases and pelvic inflammatory disease 82
Role of AST to platelet ratio index in the detection of liver fibrosis in patients with recurrent hepatitis C after liver transplantation 80
Pegylated interferon α plus ribavirin for the treatment of chronic hepatitis C: a multicentre independent study supported by the Italian Drug Agency. 80
Unveiling the Mystery of Adult-Onset Still’s Disease: A Compelling Case Report 79
Hepatitis C Virus as a Possible Helper Virus in Human Hepatitis Delta Virus Infection 78
Usefulness of six non-proprietary indirect markers of liver fibrosis in patients with chronic hepatitis C 77
Weight gain after liver transplantation and the I/D polymorphism of the angiotensin-converting enzyme gene 75
KIT/stem cell factor expression in premalignant and malignant lesions of the colon mucosa in relationship to disease progression and outcomes 74
The interleukin 28B rs12979860 C/T polymorphism and serum cholesterol as predictors of fibrosis progression in patients with chronic hepatitis C and persistently normal transaminases 74
The Impact of the G6PD Gene Mutations in Patients with Chronic Hepatitis C Infection Treated with Direct-Acting Antivirals: A Multicenter Observational Study 73
The pro-apoptotic factors Fas Ligand and Trail. Molecular mechanisms, physiopathological role and therapeutic potential 73
The c-kit/Stem Cell Factor in the cancerogenetic process of colon-rectal carcinoma. Biological and clinical aspects 73
Imatinib mesilate: New perspectives in the treatment of solid tumours 72
The Kings Score refines prognostic prediction in hepatocellular carcinoma: a novel application 71
Value of two noninvasive methods to detect progression of fibrosis among HCV carriers with normal aminotransferases 69
Imatinib mesylate: new perspectives in the treatment of solid tumours 67
The Role of Vitamin D in Autoimmune Diseases 58
Nitric Oxide Signaling in Cardiovascular Physiology and Pathology: Mechanisms, Dysregulation, and Therapeutic Frontiers 57
Evaluation of plasma interferon alpha concentration as a marker of disease severity in human psoriasis 57
Mitochondrial Dysfunction: The Cellular Bridge from Emo-tional Stress to Disease Onset. A narrative review 52
Extracellular Vesicles as Mediators of Endothelial and Tubular Injury in Cardiac Surgery-Associated Acute Kidney Injury 44
What is your next step? A case of how a misleading diagnosis can mask avoidable serious adverse effects of quetiapine 27
Thinking outside the box: a case of unexplained ascites in an adult 21
Phylogenetic and genomic characterization of whole genome sequences of a herpes simplex virus type 1 isolate identified possible virulence determinants in a human subject with fulminant hepatitis 12
Liver involvement in hospitalized patients with West Nile Virus infection 5
Totale 9.725
Salva come PNG Salva come JPEG
Categoria #
all - tutte 45.134
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.134
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022558 0 22 93 58 35 15 64 19 48 28 67 109
2022/20231.273 141 55 67 33 65 130 27 73 618 6 44 14
2023/2024490 35 54 35 15 87 8 93 17 14 11 42 79
2024/20251.406 25 7 45 20 26 70 160 86 249 135 218 365
2025/20263.981 153 151 250 541 394 238 638 696 284 309 221 106
2026/2027427 183 244 0 0 0 0 0 0 0 0 0 0
Totale 9.725